WallStSmart
CTXR

Citius Pharmaceuticals Inc

NASDAQ: CTXR · HEALTHCARE · BIOTECHNOLOGY

$0.70
+16.96% today

Updated 2026-04-30

Market cap
$17.23M
P/E ratio
P/S ratio
4.37x
EPS (TTM)
$-2.46
Dividend yield
52W range
$1 – $2
Volume
0.7M

Citius Pharmaceuticals Inc (CTXR) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201120122013201420152016201720182019202020212022202320242025
Total assets$212.00$135.00$107965.00$1.56M$741538.00$21.95M$24.42M$31.05M$28.99M$43.77M$142.43M$114.00M$103.61M$116.65M$130.94M
Cash & equivalents$212.00$135.00$54390.00$1.55M$676137.00$294351.00$3.20M$9.18M$7.89M$13.86M$70.07M$41.71M$26.48M$3.25M$4.25M
Current assets$212.00$135.00$102564.00$1.55M$736137.00$892835.00$3.42M$10.06M$7.94M$13.98M$72.81M$44.56M$34.37M$14.22M$27.93M
Total liabilities$24053.00$45982.00$14694.00$2.30M$1.38M$5.18M$2.47M$3.18M$4.61M$10.10M$9.65M$10.57M$12.18M$42.55M$53.41M
Current liabilities$24053.00$45982.00$14694.00$2.30M$1.38M$5.18M$2.47M$3.18M$4.61M$4.10M$3.98M$4.53M$5.78M$35.81M$44.91M
Long-term debt$0.00$164583.00
Shareholder equity$-23841.00$-45847.00$-14694.00$-741935.00$-635213.00$16.77M$21.95M$27.87M$24.38M$33.67M$132.18M$102.83M$90.83M$70.08M$67.55M
Retained earnings$-41841.00$-63847.00$-95216.00$-6.14M$-9.04M$-17.34M$-27.72M$-40.26M$-55.82M$-70.59M$-96.05M$-129.69M$-162.23M$-201.37M$-238.80M
Accounts receivable$0.00$818343.00
Inventory$0.00$0.00$8.27M$22.29M
Goodwill$0.00$1.59M$1.59M$1.59M$1.59M$9.35M$9.35M$9.35M$9.35M$9.35M$9.35M